Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 6/20 | 0.34 |
| ▸ | TSPO | P30536 | 2/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15480242 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL21531898 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL16641512 | 0.96 | ATM (0.38) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL21481271 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL19061249 | 0.95 | KDM4E (0.39) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL19165986 | 0.95 | KDM4E (0.39) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL19009382 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL19009380 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL19061229 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL13443995 | 0.94 | PDK2 (0.33) | KDM4EATML3MBTL1PDK2TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200229-A1 | ORGANIC LIGHT EMITTING DEVICE | CTNNB1, CYBA, CRY1 | KDM4E 2651/4885ATM 2193/4885L3MBTL1 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.